{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-133647","form_type":"8-K","ticker":"ACLS","cik":"0001113232","company_name":"AXCELIS TECHNOLOGIES INC","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.539328+00:00","generated_at":"2026-06-28T13:42:26.359211+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Axcelis Q3 revenue $176.7M, record implant systems; EPS $0.81, guides Q4 EPS $0.84","bullets":["Revenue $176.7M, up 20% QoQ; system revenue record $126.2M.","Net income $27.5M ($0.81 diluted EPS) vs $18.9M ($0.55) Q2.","Gross margin 43.3%, slightly down from 43.5% Q2.","Q4 outlook: revenue ~$190M, EPS ~$0.84; FY 2021 revenue >$640M.","Shipped Purion SiC and high-current implanters to Asia/Europe and memory customers."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-133647","json":"https://secwatch.observer/filing/0001104659-21-133647.json","markdown":"https://secwatch.observer/filing/0001104659-21-133647.md","text":"https://secwatch.observer/filing/0001104659-21-133647.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1113232/000110465921133647/0001104659-21-133647-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1113232/000110465921133647/tm2131675d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:42:26.359211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}